DOCSLIB.ORG

2016-NAM-Annual-Report.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2016-NAM-Annual-Report.Pdf National Academy of Medicine Annual Report 2016 Leadership.Innovation.Impact. for a healthier future CONTENTS About the National Academy of Medicine 2 Letter from the President 3 Organizational Chart 4 2016-2017 NAM Council 5 Our Impact Vital Directions for Health & Health Care, 7 Clinician Well-Being & Resilience , 8 Healthy Longevity Grand Challenge, 9 Culture of Health Program, 10 Human Gene Editing Initiative, 11 Prizes & Awards, 12 Emerging Leaders Forum, 12 Program Highlights Leadership Consortium for a Value & Science-Driven Health System, 13 Health Policy Educational Programs & Fellowships, 14 Innovation to Incubation, 15 Richard & Hinda Rosenthal Symposium, 15 DC Public Health Case Challenge, 15 Member Spotlight Members Elected in 2016, 17 Select Member Achievements in 2016, 18 Member Awards, 19 2016 Annual Meeting, 20 Publications 21 Finances 23 Donor Recognition 25 Remembering Ralph Cicerone 42 In Memoriam 43 Contact Information 44 About the National Academy of Medicine Founded in 1970 as the Institute of Medicine (IOM), the National Academy of Medicine (NAM) is one of three Academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies) in the United States. Operating under the 1863 Congressional charter of the National Academy of Sciences, the National Academies are private, nonprofit institutions that work outside of government to provide objective advice on matters of science, technology, and health. Studies from the National Academies are often congressionally mandated or commissioned by government agencies, and their recommendations can have lasting impact on domestic and global policy. Who We Are An independent, evidence-based scientific advisor. The NAM is committed to applying scientific rigor and objective evidence to achieve balanced, authoritative solutions to complex challenges in health. To carry out our work, we harness the talents and expertise of accomplished, thoughtful volunteers and undertake meticulous processes to avoid and balance bias. Our foundational goal is to be the nation’s most reliable source for credible scientific and policy advice on matters concerning human health. A national academy with global scope. In this increasingly interconnected world, good health knows no borders. Although the National Academies were originally created to advise the U.S. government and advance the well-being of the U.S. population, our mandate is now much broader. The NAM includes members from across the globe and partners with organizations worldwide to address challenges that affect us all. Committed to catalyzing action and achieving impact. We seek to identify and generate momentum around critical issues in health; marshal diverse expertise to build evidence-based solutions; inspire action through collaboration and public engagement; and foster the next generation of leaders and innovators. Collaborative and interdisciplinary. In partnership with the National Academy of Sciences, the National Academy of Engineering, and other stakeholders, the NAM draws on expertise across disciplines and domains to advance science, policy, and practice in health, medicine, and their many intersecting fields. Reflecting our conviction that health impacts should be a consideration in all policy decisions, we lend health and medical expertise to the broader endeavors of the Academies, including work in social sciences and education, earth and life sciences, transportation, technology, and more. An honorific society for exceptional leaders.The NAM has more than 2,000 U.S. and international members elected by their peers in recognition of outstanding achievement in health, medicine, and intersecting fields. Our members—nearly 50 of whom are Nobel laureates—are the architects of major scientific breakthroughs, policy leaders in the United States and abroad, exceptional care practitioners, and many of the brightest minds in academia. Through a commitment to volunteer service, NAM members help guide the work and advance the mission of the NAM and the National Academies. LETTER FROM THE PRESIDENT An inscription near the entrance to the Keck Center, where more than 1,000 employees of the National Academies report to work every day, bears a quote from Albert Einstein: “The right to search for truth implies also a duty; one must not conceal any part of what one has recognized to be true.” I find it fitting that the dedicated staff of the The principle that science is both a right National Academies of Sciences, Engineering, and a duty is at the heart of our mission at the and Medicine pass this reminder every morning. National Academy of Medicine (NAM). In the Too often, our society casts science as a dry and current climate, where trust in the authority of passionless endeavor, a step removed from the established institutions seems to be eroding, this world in which we operate on a daily basis. mission is more important than ever. However, This is wrong. Science, as Einstein put it so while Einstein admonishes us not to “conceal” aptly, is the search for truth. Boundless curiosity, the truth, I contend that we, as leaders in the a drive to better understand our world, is central scientific community, must go a step further. to our shared humanity and responsible for We must actively promote understanding of every technological advancement we enjoy science and the dissemination of evidence-based today. This is why, I believe, Einstein refers to the information that can improve people’s lives. pursuit of knowledge as a right. In 2016, the NAM made important strides Science cures diseases, lifts nations out of toward this goal with a sustained focus on field poverty, and breaks down false and harmful leadership, capacity building, and strategic barriers between us. Science protects our planning. In the pages that follow, you’ll find families’ health, our increasingly interconnected more detail on our special initiatives and ongoing global populations, and our complex and fragile programs—from advising the new presidential ecosystems. In short, science helps us reach administration on priorities for health and health our full potential, both as individuals and in the care to building a culture of health in every long trajectory of human progress. Therefore, community in America. we must understand science, and defend it, as a In the year ahead, we right. will redouble our efforts Einstein further contends that, as scientists, to advise the nation and we have a duty. Often, in the search for truth, the world, to identify and we reach conclusions that counter a treasured respond to emerging hypothesis or political priority. In these cases, challenges, to catalyze action more than any other, we must be entirely open and achieve impact, and to and transparent. Science is in danger when it promote the importance of becomes the instrument of an agenda. In other science wherever we go. words, to preserve our right to scientific inquiry, we must protect its integrity. Victor J. Dzau, MD President 3 Organizational Chart Chart Leadership President Home Secretary Foreign Secretary Victor J. Dzau Jane E. Henney Margaret A. Hamburg Chief of Staff: Morgan Kanarek Leonard D. Schaeffer Executive Officer J. Michael McGinnis Operations Communications Council & Membership Development Laura DeStefano Meg McCoy Julie Ische Associate Director Director Acting Director Finance & Administration Planning & Advancement Adrienne Anzanello Kimber Bogard Director Senior Officer Programs & Activities Action Collaborative on Clinician Well- Human Gene Editing Initiative (with the Being & Resilience (Charlee Alexander, National Academy of Sciences) Program Manager) Innovation to Incubation (Kimber Culture of Health Program (Kimber Bogard, Director) Bogard, Director) Leadership Consortium for a Value & DC Public Health Case Challenge Science-Driven Health System Emerging Leaders Forum (Meg McCoy, (J. Michael McGinnis, Executive Director) Director) NAM Distinguished Lecture Series Global Health Risk Framework NAM Perspectives Health Policy Educational Programs & Richard & Hinda Rosenthal Symposium Fellowships (Marie Michnich, Director) Vital Directions for Health & Health Care Healthy Longevity Grand Challenge (Elizabeth Finkelman, Program Manager) (Elizabeth Finkelman, Program Manager) 4 2016-2017 NAM Council The NAM is governed by a Council composed of NAM members elected by the membership. Victor J. Dzau, MD, Chair Lynn R. Goldman, MD,MPH Dean, School of Public Health and Health Services Tadataka Yamada, MD, Vice Chair Professor, Environmental and Occupational Health Venture Partner The George Washington University Frazier Healthcare Partners Diane E. Griffin, MD, PhD Margaret Hamburg, MD Distinguished University Service Professor Foreign Secretary Johns Hopkins Bloomberg School of Public Health Jane E. Henney, MD H. Robert Horvitz, PhD Home Secretary Investigator, Howard Hughes Medical Institute Nancy E. Adler, PhD Professor of Biology Professor of Medical Psychology Massachusetts Institute of Technology Director, Center for Health and Community Steven E. Hyman, MD University of California, San Francisco Harvard University Distinguished Service Professor Nancy Andrews, PhD, MD Director, Stanley Center for Psychiatric Research Vice Chancellor and Dean Broad Institute of MIT and Harvard Duke University School of Medicine Raynard Kington, MD, PhD Sheila P. Burke, MPA, RN President Faculty Research Fellow Grinnell College Malcolm Weiner Center for Social Policy Gilbert Omenn, MD, PhD John F. Kennedy School of Government
Load more

Recommended publications
  • Unrestricted Immigration and the Foreign Dominance Of
    Unrestricted Immigration and the Foreign Dominance of United States Nobel Prize Winners in Science: Irrefutable Data and Exemplary Family Narratives—Backup Data and Information Andrew A. Beveridge, Queens and Graduate Center CUNY and Social Explorer, Inc. Lynn Caporale, Strategic Scientific Advisor and Author The following slides were presented at the recent meeting of the American Association for the Advancement of Science. This project and paper is an outgrowth of that session, and will combine qualitative data on Nobel Prize Winners family histories along with analyses of the pattern of Nobel Winners. The first set of slides show some of the patterns so far found, and will be augmented for the formal paper. The second set of slides shows some examples of the Nobel families. The authors a developing a systematic data base of Nobel Winners (mainly US), their careers and their family histories. This turned out to be much more challenging than expected, since many winners do not emphasize their family origins in their own biographies or autobiographies or other commentary. Dr. Caporale has reached out to some laureates or their families to elicit that information. We plan to systematically compare the laureates to the population in the US at large, including immigrants and non‐immigrants at various periods. Outline of Presentation • A preliminary examination of the 609 Nobel Prize Winners, 291 of whom were at an American Institution when they received the Nobel in physics, chemistry or physiology and medicine • Will look at patterns of
    [Show full text]
  • Issues in Physics & Astronomy
    Issues in Physics & Astronomy Board on Physics and Astronomy · The National Academies · Washington, D.C. · 202-334-3520 · nationalacademies.org/bpa · Winter 2010 Unveiling the Black Hole and its Environs at the Center of the Milky Way A. Ghez, UCLA he proximity of our galaxy’s center presence of a million solar masses (Mo) • How do stars interact with super- presents us with a unique oppor- of dark matter and confined it to within a massive black holes? tunity to study a galactic nucleus radius of 0.1 pc—to a probability—when • What is the nature of the matter Twith orders of magnitude higher spatial proper motion velocity dispersion mea- flows induced by the black hole in its resolution than can be brought to bear on surements increased the inferred dark neighborhood? any other galaxy. After more than a decade mass density by 3 orders of magnitude It has been known for some time that 12 3 of diffraction-limited imaging with the to 10 Mo/pc and eliminated a cluster there is a population of young stars around rudimentary technique of speckle imag- of dark objects as a possible explana- the center of the Milky Way. The presence ing at Keck and NTT/VLT, the case for tion of the galaxy’s central dark mass of these young stars was used initially to a supermassive black hole at the galactic concentration—and finally to a certainty— argue that there could not be a black hole; center has improved dramatically. The case when individual stellar orbits confined this argument went as follows.
    [Show full text]
  • NIHAA Summer 1993
    The Newsletter of the NIH Alumni Association Summer 1993 Vol. 5, No . 2 date Nobel Laureate Harold Varmus Nominated as 14th NIH Director Ruth Kirschstein Named Acting Director President Clinton on A ug. 3 announced his intention to nominate Dr. Harold Eliot Varmus as the 14th director of th e National Institutes of Health. A Senate confirmation process must precede Yarmus· taking over leadership of the institutes. Winner of the Nobel Prize in 1989 for his work in cancer research. Va1111us. 53. is a professor of microbi­ ology. biochemistry. and biophysics. and the American Cancer Society pro­ fessor vfmoh:cu/ur >1iro/O£)' iJI l/Je Uni versity of California, San Francisco. He is a leader in the stu dy of cancer­ causing genes called "oncogenes," and an intemationall-y fecogni:z.ed authof\t-y Dr. Ruth l. Kirschsteln , acting NIH director on retroviruses. the viruses that cause Dr. Harold E. Varmus , direclor-designale AIDS and many cancers in animnl.. FIC 25 Years Old In '93 Thirty-eight-year NIH veteran Dr. Research Festival '93 Schedule Ruth Kirschstein. director of NIGM S Scholars-in-Residence (See Director p. 6) NIHAA Members Invited Program Celebrates To Alumni Symposium In This Issue Tile fas\ morning ofNCH Rc:-.c;\rch Nursing cell/er /J1·1·111111•s Festival '93-Monday. Sept. 20-has This year. the Fogarty Intern ational 17th i11s1it11tc• 111 NII/ p. ? been designated National lnsritute of Center (FIC) is 25 years old . T he cen­ Greeri11gs from 1/,11 1w11• NII /AA prl'sidt'lll. Diabetes and Digestive and Kidney Tltolll(IS .I.
    [Show full text]
  • Infection and Immunity
    INFECTION AND IMMUNITY VOLUME 56 0 JANUARY 1988 0 NUMBER 1 J. W. Shands, Jr., Editor in Chief Dexter H. Howard, Editor (1991) (1989) University of California University ofFlorida, Gainesville Peter F. Bonventre, Editor (1989) Los Angeles, Calif. Phillip J. Baker, Editor (1990) University of Cincinnati Stephen H. Leppla, Editor (1991) National Institute ofAllergy and Cincinnati, Ohio U.S. Army Medical Research Institute Infectious Diseases Roy Curtiss III, Editor (1990) of Infectious Diseases Bethesda, Md. Washington University Frederick, Md. Edwin H. Beachey, Editor (1988) St. Louis, Mo. Stephan E. Mergenhagen, Editor (1989) VA Medical Center National Institute ofDental Research Memphis, Tenn. Bethesda, Md. EDITORIAL BOARD Julia Albright (1989) Stanley Falkow (1988) Jerry R. McGhee (1988) Charles F. Schachtele (1988) Leonard t. Altman (1989) Joseph Ferretti (1989) Floyd C. McIntire (1988) Julius Schachter (1989) Michael A. Apicella (1988) Richard A. Finkelstein (1989) John Mekalanos (1989) Patrick Schlievert (1990) Neil R. Baker (1989) Vincent A. Fischetti (1989) Jiri Mestecky (1989) June R. Scott (1990) Alan Barbour (1989) David FitzGerald (1989) Suzanne M. Michalek (1989) Philip Scott (1988) John B. Bartlett (1988) Robert Fitzgerald (1989) David C. Morrison (1989) Gerald D. Shockman (1989) Joel B. Baseman (1988) James D. Folds (1988) Steven Mosely (1990) W. A. Simpson (1988) Robert E. Baughn (1990) Peter Gemski (1988) Antony J. Mukkada (1990) Phillip D. Smith (1988) Gary K. Best (1988) Robert Genco (1988) Robert S. Munford (1989) Ralph Snyderman (1988) Jenefer Blackwell (1988) Ronald J. Gibbons (1988) Juneann W. Murphy (1990) Maggie So (1989) Arnold S. Bleiweis (1990) Jon Goguen (1989) H. Nikaido (1989) P. Frederick Sparling (1990) William H.
    [Show full text]
  • A DNA Database in the NHS: Your Freedom up for Sale?
    A DNA database in the NHS: Your freedom up for sale? May 2013 In April 2013, the Caldicott Committee, including Government Chief Scientist Sir Mark Walport, proposed new rules for data-sharing which would allow the Government to build a DNA database of the whole population of England in the NHS by stealth.1 The plan is to make NHS medical records and people’s genetic information available to commercial companies and to use public-private partnerships to build a system where all private information about every citizen is also accessible to the police, social workers, security services and Government. The Wellcome Trust, which was involved in the Human Genome Project and was led by Walport for ten years, has produced a plan which involves including a variant file, containing the whole genome of every person minus the reference genome, as an attachment to every medical record in the NHS in England.2 This data would be made available to ‘researchers’ (including commercial companies) for data-mining in the cloud and personalised risk assessments would be returned to individuals. The aim is to transform the NHS in line with proposals developed more than a decade ago by former GlaxoSmithKline Chairman Sir Richard Sykes. This is expected to massively expand the market for medicines, medical tests and other products, such as supplements and cholesterol-lowering margarines, by allowing products to be marketed to individuals based on personal risk assessments, created using statistical analysis of genetic data, medical records and other health information. The proposal to build a DNA database in the NHS was endorsed by the Human Genomics Strategy Group in 20123,4 and the Government (led by Prime Minister David Cameron) has quietly adopted this recommendation without telling members of the public.
    [Show full text]
  • Information Technology R&D: Critical Trends and Issues
    DOCUMENT RESUME ED 261 643 IR 011 789 TITLE Information Technology R&D: Critical Trends and Issues. INSTITUTION Congress of the U.S., Washington, D.C. Office of Technology Assessment. REPORT NO OTA-CIT-268 PUB DATE Feb 85 NOTE 349p. AVAILABLE FROMSuperintendent of Documents, U.S. Government Printing Office, Washington, DC 20402. PUB TYPE Information Analyses (070) -- Viewpoints (120) -- Reports - Research/Technical (143) EDRS PRICE MF01/PC14 Plus Postage. DESCRIPTORS *Artificial Intelligence; Case Studies; *Computers; Foreign Countries; Information Networks; Information Science; *Research and Development; Research Projects; *Scientific Research; Technological Advancement; *Telecommunications IDENTIFIERS *Computer Architecture; *Fiber Optics; Software Engineering; United States ABSTRACT This Office of Technology Assessment report on the current state of research and development in the telecommunications industry in the United States examines four specific areas of research as case studies: computer architecture, artificial intelligence, fiber optics, and software engineering. It discusses the structure and orientation osome selected foreign programs as they challenge traditional U.S. 'market leadership in some areas of computers and communications. Fihally, it examines a set of issues that were raised in the course ok the study: manpower, institutional change, the new research organizations that grew out of Bell Laboratories, and the implications of trends in overall science and technology policy. Following an introduction and summary
    [Show full text]
  • The Spreading Cancer of Counterfeit Drugs
    The Spreading Cancer of Counterfeit Drugs The Spreading Cancer of Counterfeit Drugs Pharmaceutical Fakery Metastasizes from Lifestyle to Lifesaving Medicines Pharmaceutical Fakery Metastasizes from LifestyleBy: to Peter Lifesaving J. Pitts Medicines Former FDA Associate Commissioner President, Center By:for MedicinePeter J. Pitts in the Public Interest Former FDA Associate Commissioner President, Center for JulyMedicine 2020 in the Public Interest OctoberJuly 2020 2020 Introduction Just as the coronavirus mutates to survive and thrive, so to do the purveyors of counterfeit medicines – with their high-speed “host” being the digitization of patient care. The future is now. So, how do we balance moving forward with user-friendly digitization, telemedicine and virtual healthcare delivery while simultaneously recognizing the unintended consequences of the innovative criminal mind? The first step is to recognize there’s a problem. Counterfeit Medicines: A Moveable Feast Once upon a time, at the beginning of the new millennium, counterfeit medicines in the United States were largely “lifestyle” products such as erectile dysfunction drugs – Viagra being the poster child of the problem.i Other categories of fake pills included treatments for depression.ii The common denominator was patient shame and embarrassment. Ordering from seemingly benign (i.e., “from Canada”) websites seemed like a safe and anonymous way to address their conditions without having to visit either a physician, mental health professional or pharmacist. A second category of counterfeit prey were people seeking higher risk drugs (opioids, steroids, etc.) to facilitate a more dangerous lifestyle. The rationale for this second group was easier access to more dangerous (often controlled) substances.iii To respond to this emerging threat, the FDA formed a Counterfeit Drug Task Force in July 2003.iv As a former FDA Associate Commissioner, I was proud to serve as a member of that task force.
    [Show full text]
  • Participant Bios
    Sentinel Initiative Public Workshop Participant Biographies Mark McClellan, MD, PhD is director of the Engelberg Center for Health Care Reform and Leonard D. Schaeffer Chair in Health Policy Studies at the Brookings Institution. At the Center, his work focuses on promoting high-quality, innovative and affordable health care. A doctor and economist by training, he also has a highly distinguished record in public service and in academic research. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care. Dr. McClellan chairs the FDA’s Reagan-Udall Foundation, is co-chair of the Quality Alliance Steering Committee, sits on the National Quality Forum’s Board of Directors, is a member of the Institute of Medicine, and is a research associate at the National Bureau of Economic Research. He previously served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and was an associate professor of economics and medicine at Stanford University. Margaret Hamburg, MD is Commissioner of Food and Drugs, confirmed on May 18, 2009, by a unanimous Senate vote. The second woman to be nominated for the position, Dr. Hamburg is exceptionally qualified to serve with her training and experience as a medical doctor, scientist, and public health executive.
    [Show full text]
  • 2008 Annual Report
    2008 Annual Report NATIONAL ACADEMY OF ENGINEERING ENGINEERING THE FUTURE 1 Letter from the President 3 In Service to the Nation 3 Mission Statement 4 Program Reports 4 Engineering Education 4 Center for the Advancement of Scholarship on Engineering Education 6 Technological Literacy 6 Public Understanding of Engineering Developing Effective Messages Media Relations Public Relations Grand Challenges for Engineering 8 Center for Engineering, Ethics, and Society 9 Diversity in the Engineering Workforce Engineer Girl! Website Engineer Your Life Project Engineering Equity Extension Service 10 Frontiers of Engineering Armstrong Endowment for Young Engineers-Gilbreth Lectures 12 Engineering and Health Care 14 Technology and Peace Building 14 Technology for a Quieter America 15 America’s Energy Future 16 Terrorism and the Electric Power-Delivery System 16 U.S.-China Cooperation on Electricity from Renewables 17 U.S.-China Symposium on Science and Technology Strategic Policy 17 Offshoring of Engineering 18 Gathering Storm Still Frames the Policy Debate 20 2008 NAE Awards Recipients 22 2008 New Members and Foreign Associates 24 2008 NAE Anniversary Members 28 2008 Private Contributions 28 Einstein Society 28 Heritage Society 29 Golden Bridge Society 29 Catalyst Society 30 Rosette Society 30 Challenge Society 30 Charter Society 31 Other Individual Donors 34 The Presidents’ Circle 34 Corporations, Foundations, and Other Organizations 35 National Academy of Engineering Fund Financial Report 37 Report of Independent Certified Public Accountants 41 Notes to Financial Statements 53 Officers 53 Councillors 54 Staff 54 NAE Publications Letter from the President Engineering is critical to meeting the fundamental challenges facing the U.S. economy in the 21st century.
    [Show full text]
  • Research Into Digestive Diseases Digestive Into Research
    01Research into Digestive Diseases RESEARCH PROGRESS SUMMARY: PI: Francis Chan, Jun Yu COLORECTAL CANCER (Department of Medicine A. Molecular Pathogenesis & Therapeutics, Institute of Digestive Diseases) 1. Single-cell whole-exome sequencing has been carried out to catalogue somatic mutations in 63 cancer cells isolated from a colon cancer Team: specimen. The mutation spectrum was heterogeneous at the single- Joseph Sung, Henry Chan, cell level. The accumulation of mutations was closely related to Justin Wu, Vincent Wong, tumorigenesis based on population genetic analysis. Among them, we Siew Ng identified a high-frequency mutated gene at the single-cell level, which Technical Report on Research Progammes Technical (Department of Medicine showed low prevalence in an additional cohort study of colon cancer. & Therapeutics, Institute of Functional characterisation of the mutant gene revealed its potential Digestive Diseases), oncogenic effect in colon cancer. Alfred Cheng, William Wu 2. Whole-exome sequencing of 10 colon cancer patients identified a (Institute of Digestive Diseases), novel recurrent mutation. This mutation was detected in 23 out of 118 Enders Ng, James Lau, Simon Ng, Philip Chiu patients (20.18%) in the validation cohort. Ectopic expression of this (Department of Surgery, mutant in colon cancer cells increased cell proliferation and colony- Institute of Digestive Diseases) forming ability, caused accumulation of cells in S-phase, and enhanced in vivo tumorigenicity. The mutant protein also exhibited altered subcellular localisation. 44 01 Research into Digestive Diseases 3. A bactericidal factor known as cathelicidin secreted 2. Multivariate analysis revealed that patients with YY1 by macrophages, polymorphonuclear leukocytes, protein high expression had a significant decrease in and colonocytes was reported to contribute to colon overall survival.
    [Show full text]
  • Keynote Address Stress, Sex and the Hippocampus
    You are here: Home > research > 12th Research Day > Keynote Speaker ABSTRACT: KEYNOTE ADDRESS STRESS, SEX AND THE HIPPOCAMPUS: FROM SERENDIPITY TO CLINICAL RELEVANCE Bruce S. McEwen, PhD Lab Neuroendocrinology, Rockefeller University, New York, NY The hippocampal formation, which expresses high levels of adrenal steroid receptors, is a plastic brain structure that is important for certain types of learning and memory. It is also vulnerable to insults such as stroke, seizures and head trauma. The hippocampus is also sensitive and vulnerable to the effects of stress and stress hormones and it is responsive to the actions of sex hormones as well, both during development and adult life. Stress and sex hormones regulate 3 types of structural plasticity in the adult hippocampus: synaptogenesis, reorganization of dendrites, and neurogenesis in the dendrite gyrus. Developmentally-programmed sex differences are also seen in the hippocampus. Suppression of dentate gyrus neurogenesis and atrophy of dendrites of hippocampal pyramidal neurons are produced by chronic psychosocial stress, involving the actions of adrenal steroids acting in concert with excitatory amino acid neurotransmitters. As far as we can tell, these changes are reversible as long as stress is terminated after a number of weeks. However, there are also reports that much longer durations of psychosocial stress leads to permanent loss of hippocampal pyramidal neurons. In the human hippocampus, MRI studies along with neuropsychological testing have revealed memory impairment and atrophy of the whole human hippocampus in some individuals as they age. This is reminiscent of individual differences in aging in rodents, which appear to reflect life-long patterns of stress hormone reactivity that are developmentally programmed, although a developmental influence upon human individual differences is only a matter of speculation.
    [Show full text]
  • OFFICIAL RECORD of PROCEEDINGS Thursday, 28 May 2015 the Council Met at a Quarter Past Nine O'clock
    LEGISLATIVE COUNCIL ─ 28 May 2015 11963 OFFICIAL RECORD OF PROCEEDINGS Thursday, 28 May 2015 The Council met at a quarter past Nine o'clock MEMBERS PRESENT: THE PRESIDENT THE HONOURABLE JASPER TSANG YOK-SING, G.B.S., J.P. THE HONOURABLE ALBERT HO CHUN-YAN THE HONOURABLE LEE CHEUK-YAN THE HONOURABLE JAMES TO KUN-SUN THE HONOURABLE CHAN KAM-LAM, S.B.S., J.P. THE HONOURABLE LEUNG YIU-CHUNG THE HONOURABLE EMILY LAU WAI-HING, J.P. THE HONOURABLE TAM YIU-CHUNG, G.B.S., J.P. THE HONOURABLE ABRAHAM SHEK LAI-HIM, G.B.S., J.P. THE HONOURABLE TOMMY CHEUNG YU-YAN, S.B.S., J.P. THE HONOURABLE FREDERICK FUNG KIN-KEE, S.B.S., J.P. THE HONOURABLE WONG KWOK-HING, B.B.S., M.H. PROF THE HONOURABLE JOSEPH LEE KOK-LONG, S.B.S., J.P., Ph.D., R.N. 11964 LEGISLATIVE COUNCIL ─ 28 May 2015 THE HONOURABLE JEFFREY LAM KIN-FUNG, G.B.S., J.P. THE HONOURABLE ANDREW LEUNG KWAN-YUEN, G.B.S., J.P. THE HONOURABLE WONG TING-KWONG, S.B.S., J.P. THE HONOURABLE RONNY TONG KA-WAH, S.C. THE HONOURABLE CYD HO SAU-LAN, J.P. THE HONOURABLE STARRY LEE WAI-KING, J.P. DR THE HONOURABLE LAM TAI-FAI, S.B.S., J.P. THE HONOURABLE CHAN HAK-KAN, J.P. THE HONOURABLE CHAN KIN-POR, B.B.S., J.P. DR THE HONOURABLE PRISCILLA LEUNG MEI-FUN, S.B.S., J.P. THE HONOURABLE CHEUNG KWOK-CHE THE HONOURABLE WONG KWOK-KIN, S.B.S.
    [Show full text]